Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of > 2 years of follow-up
Loading...
Date
Authors
Fradet, Y.
Bellmunt, J.
Vaughn, D.J.
Lee, J.L.
Fong, L.
Vogelzang, N.J.
Gerritsen, W.R. Winald
Wit, R. de
Bajorin, D.F.